Oct 08, 2019 6:15am EDT Lexaria Bioscience Provides Update on R&D Program Progress under License Agreement with Altria
Sep 17, 2019 6:15am EDT Peer Reviewed Clinical Journal Publishes Lexaria Bioscience's Human CBD Study Results
Sep 06, 2019 8:30am EDT Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Featured in NetworkNewsAudio Publication Discussing Innovative Drug-Delivery Discovery
Sep 05, 2019 8:30am EDT Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Featured in NetworkNewsWire Publication Reporting on Momentous Advances in Drug-Delivery Innovation
Aug 27, 2019 6:15am EDT Lexaria Bioscience Announces DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids to Treat Certain Disease Conditions
Aug 22, 2019 6:15am EDT Lexaria Announces Commercial Launch of ChrgD+ Odorless, Flavorless, Water-Soluble Powdered Hemp Oil
Aug 14, 2019 6:15am EDT Lexaria’s Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of Directors
